We are pleased to share that a Phase I/II Intracerebral Gene Therapy clinical trial for MLD is now recruiting late infantile MLD patients. Dr. Patrick Aubourg and Dr. Caroline Sevin are the co-Principal Investigators.
We have posted complete details of the trial, including inclusion criteria, here.
This trial is based on many years of work in the lab, and on some parallel work with ALD that showed good results.